Ensysce Biosciences Inc (ENSC)

Jan 09, 2026

Ensysce Biosciences Annual Meeting: Share Issuance Approved, PF614 Phase III and FDA Designations Update - Defense World

Jan 09, 2026

Jan 09, 2026

Why Ensysce Biosciences Inc. stock is seen as undervaluedJuly 2025 Sector Moves & AI Based Trade Execution Alerts - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Why Ensysce Biosciences Inc. stock could be next big winnerWeekly Trade Report & AI Forecasted Stock Moves - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Ensysce Biosciences Shareholders Approve Key Corporate Actions - TipRanks

Jan 08, 2026

Jan 08, 2026

How Ensysce Biosciences Inc. stock compares to growth peersWeekly Gains Report & Safe Capital Growth Stock Tips - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How rising interest rates impact Ensysce Biosciences Inc. stockJuly 2025 Setups & Daily Technical Forecast Reports - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Can Ensysce Biosciences Inc. stock resist market sell offsQuarterly Risk Review & Step-by-Step Trade Execution Guides - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

MarketsMedicine Hat News - FinancialContent

Jan 08, 2026

Jan 07, 2026

How Ensysce Biosciences Inc. stock reacts to Fed rate cutsSell Signals and Alerts & Low Cost Trading Plans - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Ensysce Biosciences, Inc.Common Stock (NQ: ENSC - FinancialContent

Jan 07, 2026

Jan 07, 2026

ENSC: All proposals passed and clinical programs advanced, setting the stage for a pivotal year - TradingView — Track All Markets

Jan 07, 2026

Jan 06, 2026

Ensysce’s PF614 Steps Forward in Phase 3 Post-Surgery Pain Trial: What Investors Should Watch - TipRanks

Jan 06, 2026

Jan 05, 2026

Ensysce Biosciences Issues Annual Shareholder Letter - The Globe and Mail

Jan 05, 2026

Jan 05, 2026

Ensysce Biosciences advances phase 3 trial for abuse-resistant opioid By Investing.com - Investing.com India

Jan 05, 2026

Jan 05, 2026

Inside a biotech developing pain pills with built-in overdose protection - Stock Titan

Jan 05, 2026

Dec 29, 2025

Ensysce Biosciences, Inc. (NASDAQ:ENSC) Short Interest Up 188.9% in December - Defense World

Dec 29, 2025

Dec 21, 2025

Will Ensysce Biosciences Inc. stock maintain growth storyWeekly Profit Recap & Free Community Supported Trade Ideas - Улправда

Dec 21, 2025

Dec 21, 2025

Ensysce Biosciences’ Innovative Approach to Safer Opioid Use: A Clinical Study Update - MSN

Dec 21, 2025

Dec 21, 2025

What sentiment indicators say about Ensysce Biosciences Inc. stockTrade Entry Summary & Fast Momentum Entry Tips - Улправда

Dec 21, 2025

Dec 21, 2025

Why Ensysce Biosciences Inc. stock is considered a top pick2025 Trading Volume Trends & Weekly Stock Breakout Alerts - Улправда

Dec 21, 2025

Dec 20, 2025

How buybacks impact Ensysce Biosciences Inc. stock valueEarnings Performance Report & Community Shared Stock Ideas - Улправда

Dec 20, 2025

Dec 20, 2025

Can Ensysce Biosciences Inc. stock maintain operating margins2025 AllTime Highs & Verified Stock Trade Ideas - Улправда

Dec 20, 2025

Dec 19, 2025

Resistance Check: Can Ensysce Biosciences Inc. stock maintain operating marginsMarket Performance Report & High Return Trade Guides - Улправда

Dec 19, 2025

Dec 15, 2025

Ensysce Biosciences Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

EBIT per share of Ensysce Biosciences Inc. – OTC:ENSCW - TradingView — Track All Markets

Dec 13, 2025

Dec 11, 2025

ENSC enrolls first patient in critical phase 3 trial - MSN

Dec 11, 2025

Dec 11, 2025

Ensysce Biosciences initiates enrollment in Phase 3 trial of PF614 - MSN

Dec 11, 2025

Dec 10, 2025

Ensysce Biosciences enrolls first patient in phase 3 pain drug trial - Investing.com Australia

Dec 10, 2025

Dec 09, 2025

Should You Buy Ensysce Biosciences After Share Sale? - StocksToTrade

Dec 09, 2025

Dec 09, 2025

Is Ensysce Biosciences a Hidden Gem? - timothysykes.com

Dec 09, 2025

Dec 09, 2025

Ensysce Biosciences enrolls first patient in phase 3 pain drug trial By Investing.com - Investing.com South Africa

Dec 09, 2025

Dec 09, 2025

Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid - Corsicana Daily Sun

Dec 09, 2025

Dec 09, 2025

Ensysce Biosciences (NASDAQ: ENSC) starts Phase 3 PF614 trial in abuse-deterrent opioid - Stock Titan

Dec 09, 2025

Dec 04, 2025

How Ensysce Biosciences Inc. stock performs in interest rate cyclesQuarterly Profit Review & Real-Time Buy Signal Notifications - Newser

Dec 04, 2025

Dec 03, 2025

Why Ensysce Biosciences Inc. stock attracts high net worth investorsIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser

Dec 03, 2025

Dec 02, 2025

Ensysce (NASDAQ: ENSC) secures MPAR overdose tech patent protection to 2042 - Stock Titan

Dec 02, 2025

Dec 02, 2025

Is Ensysce Biosciences Inc. stock near bottom after declineEarnings Beat & Weekly High Conviction Trade Ideas - Newser

Dec 02, 2025

Dec 02, 2025

Will Ensysce Biosciences Inc. stock outperform international peersProfit Target & Verified Stock Trade Ideas - Newser

Dec 02, 2025

Dec 01, 2025

Ensysce Biosciences (ENSC) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 28, 2025

Earnings Beat: Why Ensysce Biosciences Inc. stock is seen as undervalued2025 Volatility Report & Fast Gaining Stock Reports - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Is Ensysce Biosciences, Inc. overvalued or undervalued? - Markets Mojo

Nov 28, 2025

Nov 24, 2025

Ensysce Biosciences Inc. (ENSC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 24, 2025

Nov 21, 2025

[PRE 14A] Ensysce Biosciences, Inc. Preliminary Proxy Statement - Stock Titan

Nov 21, 2025

Nov 21, 2025

Will Ensysce Biosciences Inc. stock benefit from AI adoption2025 Volatility Report & Community Shared Stock Ideas - newser.com

Nov 21, 2025